Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03107663
What this trial is testing

⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma

Who this might be right for
Positron-Emission TomographyImmunomodulationMetastatic Solid Malignancies+1 more
ImaginAb, Inc. 15
Large-scale testing (Phase 3)Ended earlyNCT04335006
What this trial is testing

Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer.

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 80
Testing effectiveness (Phase 2)Ended earlyNCT00674206
What this trial is testing

A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Emory University 6
Testing effectiveness (Phase 2)WithdrawnNCT05209529
What this trial is testing

Chemo-free BRCA-targeted Neoadjuvant Strategy

Who this might be right for
TNBC - Triple-Negative Breast CancerBRCA1 MutationBRCA2 Mutation
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Ended earlyNCT02720185
What this trial is testing

Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR

Who this might be right for
Breast NeoplasmsTriple Negative Breast Neoplasms
University of Wisconsin, Madison 5
Not applicableEnded earlyNCT05435352
What this trial is testing

Image-based AI Predictive Biomarkers for Precision Neoadjuvant Triple-negative Breast Cancer Treatment

Who this might be right for
Triple Negative Breast CancerTriple Negative Breast Neoplasms
Ourotech, Inc. 34
Not applicableActive Not RecruitingNCT06418126
What this trial is testing

Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Centre Paul Strauss 15
Early research (Phase 1)Active Not RecruitingNCT01251874
What this trial is testing

Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer

Who this might be right for
Recurrent Breast CarcinomaStage IIIB Breast Cancer AJCC v7Stage IIIC Breast Cancer AJCC v7+2 more
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Looking for participantsNCT07407920
What this trial is testing

Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Early Stage HER2-Positive Breast Carcinoma+1 more
M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)Ended earlyNCT05219578
What this trial is testing

RTX-224 Monotherapy in Patients With Solid Tumors

Who this might be right for
Non Small Cell Lung CancerCutaneous MelanomaHead and Neck Squamous Cell Carcinoma+2 more
Rubius Therapeutics 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT02422498
What this trial is testing

Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy

Who this might be right for
Locally Recurrent/Metastatic Triple Negative Breast Cancer
Memorial Sloan Kettering Cancer Center 49
Testing effectiveness (Phase 2)Ended earlyNCT02322814
What this trial is testing

Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has Spread

Who this might be right for
Breast Cancer
Hoffmann-La Roche 169
Early research (Phase 1)Study completedNCT04105582
What this trial is testing

Breast Cancer Neoantigen Vaccination With Autologous Dendritic Cells

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Universidad Nacional de Colombia 5
Testing effectiveness (Phase 2)Ended earlyNCT03225547
What this trial is testing

Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer

Who this might be right for
Triple Negative Breast NeoplasmsBreast Cancer
University of Chicago 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06407310
What this trial is testing

Neoadjuvant Pembrolizumab, Carboplatin and Paclitaxel in Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Tel Aviv Medical Center 25
Early research (Phase 1)Study completedNCT03218826
What this trial is testing

PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Prostate Carcinoma+23 more
National Cancer Institute (NCI) 23
Not applicableLooking for participantsNCT06505018
What this trial is testing

Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment

Who this might be right for
Metastatic Triple-Negative Breast Carcinoma
UNICANCER 472
Testing effectiveness (Phase 2)Looking for participantsNCT05019690
What this trial is testing

Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer

Who this might be right for
Advanced Triple Negative Breast Cancer
Fujian Cancer Hospital 29
Testing effectiveness (Phase 2)Ended earlyNCT01918306
What this trial is testing

GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor Negative Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastTriple Negative Breast Cancer+3 more
Vanderbilt-Ingram Cancer Center 11
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07359404
What this trial is testing

Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC

Who this might be right for
Advanced Breast Cancer
YING FAN 60
Next Page